Inventor

FERRARA KOLLER CLAUDIA

CH21 patents

⚠️ This page may combine multiple inventors who share the name “FERRARA KOLLER CLAUDIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FERRARA KOLLER CLAUDIA

HOFFMANN LA ROCHE

Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer

Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer

Bispecific antibodies specific for OX40

Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules

Bispecific antigen binding molecules comprising anti-4-1BB clone 20H4.9

Humanized anti-human CD19 antibodies and methods of use

Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists

Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

Combination therapy with targeted 4-1BB (CD137) agonists

Bispecific antibodies specific for OX40

Humanized anti-human CD19 antibodies and methods of use

Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof

Bispecific 2+1 contorsbodies

HER2-targeting antigen binding molecules comprising 4-1BBL

Anti-human CD19 antibodies with high affinity

Combination therapy with targeted 4-1BB (CD137) agonists/anti-FAP binding domain and anti-CEA/anti-CD3 bispecific antibody

ROCHE GLYCART AG

Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5

Antibodies specific for DR5 and methods of use

BRUENKER PETER

DR5—FAP bispecific death receptor agonistic antibodies

HOFFMANN—LA ROCHE INC

Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety

UMAÑA PABLO

Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function